<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02693340</url>
  </required_header>
  <id_info>
    <org_study_id>P150702</org_study_id>
    <nct_id>NCT02693340</nct_id>
  </id_info>
  <brief_title>Evolution of Lymphocyte Populations Under Biotherapy in Inflammatory Bowel Disease</brief_title>
  <acronym>IBDOT</acronym>
  <official_title>Evolution of Lymphocyte Populations Under Biotherapy in Inflammatory Bowel Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a monocentric prospective study for the collection of biological samples (blood and
      biopsies) to be used for in vitro biomarker assay(s) performed to identify predictive markers
      of response to biological treatments in inflammatory bowel disease (IBD).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Anticipated">March 2020</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Response to biological treatments</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Microbiota variation</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Inflammatory Bowel Disease</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>sampling</intervention_name>
    <description>• Sampling period(s):
Blood: W0, W6, W14, W30 and W52 and relapse.
Biopsies and fecal: W0, W14 and M52 and relapse.</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      • Sampling period(s):

        -  Blood: W0, W6, W14, W30 and W52 and relapse.

        -  Biopsies and fecal: W0, W14 and M52 and relapse.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Crohn's Disease Diagnosis (CD) or ulcerative colitis (UC)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged 18 or more.

          -  Crohn's Disease Diagnosis (CD) or ulcerative colitis (UC) according to defined
             criteria (ECCO recommendations).

          -  Active disease as defined by clinical biological and/or morphological assessment.

          -  Initiation of an anti-Tumor Necrosis Factor (TNF) therapy (Infliximab, Adalimumab,
             Golimumab) or new biotherapy (Vedolizumab, Ustekinumab) provided in connection with
             the management of digestive disease.

          -  Patient (e) have signed and dated consent of the study before undertaking procedures
             related to the study.

        Exclusion Criteria:

          -  Patients under guardianship / curators

          -  Following Situations

               -  Persons unable to understand, read and / or sign an informed consent

               -  Patient with the following functions: investigator or co-investigator, research
                  assistant, pharmacist, study coordinator or having any involvement in the study

               -  Uncooperative person or potentially non-compliant for the study and its
                  procedures with predictable difficulties regular monitoring of over 1 year.

               -  No affiliation to a social security scheme, a universal medical coverage or any
                  similar plan.

          -  Pregnant or lactating women.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthieu Allez, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>APHP</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Matthieu Allez, MDPhD</last_name>
    <phone>+33 1 42 49 95 97</phone>
    <email>matthieu.allez@aphp.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Gastroenterology department</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthieu Allez, MDPhD</last_name>
      <email>matthieu.allez@aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 23, 2016</study_first_submitted>
  <study_first_submitted_qc>February 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 26, 2016</study_first_posted>
  <last_update_submitted>June 23, 2016</last_update_submitted>
  <last_update_submitted_qc>June 23, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 24, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intestinal Diseases</mesh_term>
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

